Additionally, we examined the molecular mechanisms of metastasis and examined therapeutic strategies to overcome tumor growth and metastasis in SMARCB1-deficient BLCA driven by STAT3 pathway upregulation. This evidence concerns the gene SMARCB1 and bladder transitional cell carcinoma.